Second-line FOLFOX chemotherapy for advanced biliary tract cancer - Authors' reply

Lamarca, Angela; Palmer, D. H.; Wasan, H. S.; Ross, P. J.; Ma, Y. T.; Arora, A.; Falk, S.; Gillmore, R.; Wadsley, J.; Patel, K.; Anthoney, A.; Maraveyas, A.; Iveson, T.; Waters, J. S.; Hobbs, C.; Barber, S.; Ryder, W. D.; Ramage, J.; Davies, L. M.; Bridgewater, J. A; Valle, Juan W

Affiliation

Department of Medical Oncology, The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester, Manchester M20 4BX

Issue Date

2021

Metadata

Show full item record

Abstract

None

Citation

Lamarca A, Palmer DH, Wasan HS, Ross PJ, Ma YT, Arora A, et al. Second-line FOLFOX chemotherapy for advanced biliary tract cancer – Authors’ reply. The Lancet Oncology. 2021 Jul;22(7):e288–9.

Journal

Lancet Oncology

URI

http://hdl.handle.net/10541/624466

DOI

10.1016/s1470-2045(21)00341-7

PubMed ID

34197751

Additional Links

https://dx.doi.org/10.1016/s1470-2045(21)00341-7

Type

Other

Language

Collections

All Christie Publications